Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies
Background The incidence of incisional hernia in patients with peritoneal surface malignancies treated by cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) remains unclear, and the criteria commonly used to indicate their repair cannot be applied in these patients. The objective o...
Gespeichert in:
| Veröffentlicht in: | Hernia : the journal of hernias and abdominal wall surgery 2020-04, Vol.24 (2), p.257-263 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 263 |
|---|---|
| container_issue | 2 |
| container_start_page | 257 |
| container_title | Hernia : the journal of hernias and abdominal wall surgery |
| container_volume | 24 |
| creator | Cascales Campos, P. A. González-Gil, A. Gómez-Ruiz, A. J. Gil-Gómez, E. Alconchel-Gago, F. Navarro-Barrios, A. Martínez-García, J. Alonso-Romero, J. L. Nieto, A. Barceló-Valcarcel, F. Gil-Martínez, J. |
| description | Background
The incidence of incisional hernia in patients with peritoneal surface malignancies treated by cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) remains unclear, and the criteria commonly used to indicate their repair cannot be applied in these patients. The objective of this work was to analyze the incidence of incisional hernias in these patients, identify the risk factors associated with their appearance, and propose an algorithm for their management.
Methods
We analyzed a series of patients with malignant pathologies of the peritoneal surface treated by cytoreduction with peritonectomy and HIPEC procedures between January 2008 and June 2017. Only patients with a minimum postoperative follow-up period of 12 months were included.
Results
Our series included 282 patients, 28 (10%) of whom developed an incisional hernia during the follow-up period. Fifty-one patients, all with ovarian cancer with peritoneal dissemination, did not receive HIPEC after cytoreduction as they were part of the control arm of the CARCINOHIPEC clinical trial (NCT02328716) or because they did not provide specific informed consent. In the multivariate analysis, treatment with HIPEC (OR 2.56, 95% CI [1.57, 4.31],
p
= 0.032) and the administration of preoperative systemic chemotherapy (OR = 1.59, 95% CI [1.26, 3.58],
p
= 0.041) were found to be independent factors related to the appearance of an incisional hernia.
Conclusions
The incidence of incisional hernia after cytoreduction and HIPEC is within the ranges described in the literature for other abdominal surgery procedures. The use of systemic chemotherapy and treatment with HIPEC, in particular, were identified as factors related to their occurrence
. |
| doi_str_mv | 10.1007/s10029-019-01962-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2221563696</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2221563696</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-5d3ea7b25f18c87fae17581468455527e02c775c6c02a2f586fe263d9b2b2eb93</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi1ERT_gD3BAlrjQQ4rtxHZyRKtCK1UqQnC2HGe867Jxgu0I7W_iT3Z2t3ycONgea95nZuyXkNecXXHG9PuMu-gqxg9Liap5Rs64aNqqE6x5vo-VrJqOqVNynvMDY6xtVPuCnNacqU7q7oz8-hLyd-qtK1PK1MaBjjbaNYwQC508DdGFHKZot3QDKQZLrS-QqNshAMPiCiYP3GY3QyooGoNDrCSL91CmCMi6DYzTPmnnHX13c_v5enWJIjrbErBTpj9D2dB_gLwkHApwmm1YR4tTQH5JTrzdZnj1dF6Qbx-vv65uqrv7T7erD3eVq7UslRxqsLoX0vPWtdpb4Fq2HF_eSCmFBiac1tIpx4QVXrbKg1D10PWiF9B39QV5e6w7p-nHArmYh2lJ-AXZCCG4VLXqFKrEUeXSlHMCb-YURpt2hjOz98cc_THojTn4YxqE3jyVXvoRhj_Ib0NQUB8FGVNxDelv7_-UfQTPPJ88</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2221563696</pqid></control><display><type>article</type><title>Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Cascales Campos, P. A. ; González-Gil, A. ; Gómez-Ruiz, A. J. ; Gil-Gómez, E. ; Alconchel-Gago, F. ; Navarro-Barrios, A. ; Martínez-García, J. ; Alonso-Romero, J. L. ; Nieto, A. ; Barceló-Valcarcel, F. ; Gil-Martínez, J.</creator><creatorcontrib>Cascales Campos, P. A. ; González-Gil, A. ; Gómez-Ruiz, A. J. ; Gil-Gómez, E. ; Alconchel-Gago, F. ; Navarro-Barrios, A. ; Martínez-García, J. ; Alonso-Romero, J. L. ; Nieto, A. ; Barceló-Valcarcel, F. ; Gil-Martínez, J.</creatorcontrib><description>Background
The incidence of incisional hernia in patients with peritoneal surface malignancies treated by cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) remains unclear, and the criteria commonly used to indicate their repair cannot be applied in these patients. The objective of this work was to analyze the incidence of incisional hernias in these patients, identify the risk factors associated with their appearance, and propose an algorithm for their management.
Methods
We analyzed a series of patients with malignant pathologies of the peritoneal surface treated by cytoreduction with peritonectomy and HIPEC procedures between January 2008 and June 2017. Only patients with a minimum postoperative follow-up period of 12 months were included.
Results
Our series included 282 patients, 28 (10%) of whom developed an incisional hernia during the follow-up period. Fifty-one patients, all with ovarian cancer with peritoneal dissemination, did not receive HIPEC after cytoreduction as they were part of the control arm of the CARCINOHIPEC clinical trial (NCT02328716) or because they did not provide specific informed consent. In the multivariate analysis, treatment with HIPEC (OR 2.56, 95% CI [1.57, 4.31],
p
= 0.032) and the administration of preoperative systemic chemotherapy (OR = 1.59, 95% CI [1.26, 3.58],
p
= 0.041) were found to be independent factors related to the appearance of an incisional hernia.
Conclusions
The incidence of incisional hernia after cytoreduction and HIPEC is within the ranges described in the literature for other abdominal surgery procedures. The use of systemic chemotherapy and treatment with HIPEC, in particular, were identified as factors related to their occurrence
.</description><identifier>ISSN: 1265-4906</identifier><identifier>EISSN: 1248-9204</identifier><identifier>DOI: 10.1007/s10029-019-01962-4</identifier><identifier>PMID: 31069579</identifier><language>eng</language><publisher>Paris: Springer Paris</publisher><subject>Abdominal Surgery ; Adolescent ; Adult ; Aged ; Algorithms ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; Chemotherapy ; Cytoreduction Surgical Procedures - adverse effects ; Female ; Forum on Complexities in Hernia ; Gastric cancer ; Hernia ; Hernias ; Herniorrhaphy ; Humans ; Hyperthermic Intraperitoneal Chemotherapy - adverse effects ; Incidence ; Incisional Hernia - epidemiology ; Incisional Hernia - etiology ; Incisional Hernia - surgery ; Medicine ; Medicine & Public Health ; Middle Aged ; Multivariate analysis ; Original Article ; Ovarian cancer ; Ovarian Neoplasms - drug therapy ; Ovarian Neoplasms - pathology ; Ovarian Neoplasms - surgery ; Patients ; Peritoneal Neoplasms - drug therapy ; Peritoneal Neoplasms - secondary ; Peritoneal Neoplasms - surgery ; Peritoneum ; Peritoneum - pathology ; Peritoneum - surgery ; Retrospective Studies ; Risk Factors ; Spain - epidemiology ; Surgery ; Young Adult</subject><ispartof>Hernia : the journal of hernias and abdominal wall surgery, 2020-04, Vol.24 (2), p.257-263</ispartof><rights>Springer-Verlag France SAS, part of Springer Nature 2019</rights><rights>Hernia is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-5d3ea7b25f18c87fae17581468455527e02c775c6c02a2f586fe263d9b2b2eb93</citedby><cites>FETCH-LOGICAL-c375t-5d3ea7b25f18c87fae17581468455527e02c775c6c02a2f586fe263d9b2b2eb93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10029-019-01962-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10029-019-01962-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31069579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cascales Campos, P. A.</creatorcontrib><creatorcontrib>González-Gil, A.</creatorcontrib><creatorcontrib>Gómez-Ruiz, A. J.</creatorcontrib><creatorcontrib>Gil-Gómez, E.</creatorcontrib><creatorcontrib>Alconchel-Gago, F.</creatorcontrib><creatorcontrib>Navarro-Barrios, A.</creatorcontrib><creatorcontrib>Martínez-García, J.</creatorcontrib><creatorcontrib>Alonso-Romero, J. L.</creatorcontrib><creatorcontrib>Nieto, A.</creatorcontrib><creatorcontrib>Barceló-Valcarcel, F.</creatorcontrib><creatorcontrib>Gil-Martínez, J.</creatorcontrib><title>Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies</title><title>Hernia : the journal of hernias and abdominal wall surgery</title><addtitle>Hernia</addtitle><addtitle>Hernia</addtitle><description>Background
The incidence of incisional hernia in patients with peritoneal surface malignancies treated by cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) remains unclear, and the criteria commonly used to indicate their repair cannot be applied in these patients. The objective of this work was to analyze the incidence of incisional hernias in these patients, identify the risk factors associated with their appearance, and propose an algorithm for their management.
Methods
We analyzed a series of patients with malignant pathologies of the peritoneal surface treated by cytoreduction with peritonectomy and HIPEC procedures between January 2008 and June 2017. Only patients with a minimum postoperative follow-up period of 12 months were included.
Results
Our series included 282 patients, 28 (10%) of whom developed an incisional hernia during the follow-up period. Fifty-one patients, all with ovarian cancer with peritoneal dissemination, did not receive HIPEC after cytoreduction as they were part of the control arm of the CARCINOHIPEC clinical trial (NCT02328716) or because they did not provide specific informed consent. In the multivariate analysis, treatment with HIPEC (OR 2.56, 95% CI [1.57, 4.31],
p
= 0.032) and the administration of preoperative systemic chemotherapy (OR = 1.59, 95% CI [1.26, 3.58],
p
= 0.041) were found to be independent factors related to the appearance of an incisional hernia.
Conclusions
The incidence of incisional hernia after cytoreduction and HIPEC is within the ranges described in the literature for other abdominal surgery procedures. The use of systemic chemotherapy and treatment with HIPEC, in particular, were identified as factors related to their occurrence
.</description><subject>Abdominal Surgery</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Algorithms</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Chemotherapy</subject><subject>Cytoreduction Surgical Procedures - adverse effects</subject><subject>Female</subject><subject>Forum on Complexities in Hernia</subject><subject>Gastric cancer</subject><subject>Hernia</subject><subject>Hernias</subject><subject>Herniorrhaphy</subject><subject>Humans</subject><subject>Hyperthermic Intraperitoneal Chemotherapy - adverse effects</subject><subject>Incidence</subject><subject>Incisional Hernia - epidemiology</subject><subject>Incisional Hernia - etiology</subject><subject>Incisional Hernia - surgery</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Original Article</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - drug therapy</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Patients</subject><subject>Peritoneal Neoplasms - drug therapy</subject><subject>Peritoneal Neoplasms - secondary</subject><subject>Peritoneal Neoplasms - surgery</subject><subject>Peritoneum</subject><subject>Peritoneum - pathology</subject><subject>Peritoneum - surgery</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Spain - epidemiology</subject><subject>Surgery</subject><subject>Young Adult</subject><issn>1265-4906</issn><issn>1248-9204</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU1v1DAQhi1ERT_gD3BAlrjQQ4rtxHZyRKtCK1UqQnC2HGe867Jxgu0I7W_iT3Z2t3ycONgea95nZuyXkNecXXHG9PuMu-gqxg9Liap5Rs64aNqqE6x5vo-VrJqOqVNynvMDY6xtVPuCnNacqU7q7oz8-hLyd-qtK1PK1MaBjjbaNYwQC508DdGFHKZot3QDKQZLrS-QqNshAMPiCiYP3GY3QyooGoNDrCSL91CmCMi6DYzTPmnnHX13c_v5enWJIjrbErBTpj9D2dB_gLwkHApwmm1YR4tTQH5JTrzdZnj1dF6Qbx-vv65uqrv7T7erD3eVq7UslRxqsLoX0vPWtdpb4Fq2HF_eSCmFBiac1tIpx4QVXrbKg1D10PWiF9B39QV5e6w7p-nHArmYh2lJ-AXZCCG4VLXqFKrEUeXSlHMCb-YURpt2hjOz98cc_THojTn4YxqE3jyVXvoRhj_Ib0NQUB8FGVNxDelv7_-UfQTPPJ88</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Cascales Campos, P. A.</creator><creator>González-Gil, A.</creator><creator>Gómez-Ruiz, A. J.</creator><creator>Gil-Gómez, E.</creator><creator>Alconchel-Gago, F.</creator><creator>Navarro-Barrios, A.</creator><creator>Martínez-García, J.</creator><creator>Alonso-Romero, J. L.</creator><creator>Nieto, A.</creator><creator>Barceló-Valcarcel, F.</creator><creator>Gil-Martínez, J.</creator><general>Springer Paris</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200401</creationdate><title>Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies</title><author>Cascales Campos, P. A. ; González-Gil, A. ; Gómez-Ruiz, A. J. ; Gil-Gómez, E. ; Alconchel-Gago, F. ; Navarro-Barrios, A. ; Martínez-García, J. ; Alonso-Romero, J. L. ; Nieto, A. ; Barceló-Valcarcel, F. ; Gil-Martínez, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-5d3ea7b25f18c87fae17581468455527e02c775c6c02a2f586fe263d9b2b2eb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abdominal Surgery</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Algorithms</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Chemotherapy</topic><topic>Cytoreduction Surgical Procedures - adverse effects</topic><topic>Female</topic><topic>Forum on Complexities in Hernia</topic><topic>Gastric cancer</topic><topic>Hernia</topic><topic>Hernias</topic><topic>Herniorrhaphy</topic><topic>Humans</topic><topic>Hyperthermic Intraperitoneal Chemotherapy - adverse effects</topic><topic>Incidence</topic><topic>Incisional Hernia - epidemiology</topic><topic>Incisional Hernia - etiology</topic><topic>Incisional Hernia - surgery</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Original Article</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - drug therapy</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Patients</topic><topic>Peritoneal Neoplasms - drug therapy</topic><topic>Peritoneal Neoplasms - secondary</topic><topic>Peritoneal Neoplasms - surgery</topic><topic>Peritoneum</topic><topic>Peritoneum - pathology</topic><topic>Peritoneum - surgery</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Spain - epidemiology</topic><topic>Surgery</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cascales Campos, P. A.</creatorcontrib><creatorcontrib>González-Gil, A.</creatorcontrib><creatorcontrib>Gómez-Ruiz, A. J.</creatorcontrib><creatorcontrib>Gil-Gómez, E.</creatorcontrib><creatorcontrib>Alconchel-Gago, F.</creatorcontrib><creatorcontrib>Navarro-Barrios, A.</creatorcontrib><creatorcontrib>Martínez-García, J.</creatorcontrib><creatorcontrib>Alonso-Romero, J. L.</creatorcontrib><creatorcontrib>Nieto, A.</creatorcontrib><creatorcontrib>Barceló-Valcarcel, F.</creatorcontrib><creatorcontrib>Gil-Martínez, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Hernia : the journal of hernias and abdominal wall surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cascales Campos, P. A.</au><au>González-Gil, A.</au><au>Gómez-Ruiz, A. J.</au><au>Gil-Gómez, E.</au><au>Alconchel-Gago, F.</au><au>Navarro-Barrios, A.</au><au>Martínez-García, J.</au><au>Alonso-Romero, J. L.</au><au>Nieto, A.</au><au>Barceló-Valcarcel, F.</au><au>Gil-Martínez, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies</atitle><jtitle>Hernia : the journal of hernias and abdominal wall surgery</jtitle><stitle>Hernia</stitle><addtitle>Hernia</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>24</volume><issue>2</issue><spage>257</spage><epage>263</epage><pages>257-263</pages><issn>1265-4906</issn><eissn>1248-9204</eissn><abstract>Background
The incidence of incisional hernia in patients with peritoneal surface malignancies treated by cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) remains unclear, and the criteria commonly used to indicate their repair cannot be applied in these patients. The objective of this work was to analyze the incidence of incisional hernias in these patients, identify the risk factors associated with their appearance, and propose an algorithm for their management.
Methods
We analyzed a series of patients with malignant pathologies of the peritoneal surface treated by cytoreduction with peritonectomy and HIPEC procedures between January 2008 and June 2017. Only patients with a minimum postoperative follow-up period of 12 months were included.
Results
Our series included 282 patients, 28 (10%) of whom developed an incisional hernia during the follow-up period. Fifty-one patients, all with ovarian cancer with peritoneal dissemination, did not receive HIPEC after cytoreduction as they were part of the control arm of the CARCINOHIPEC clinical trial (NCT02328716) or because they did not provide specific informed consent. In the multivariate analysis, treatment with HIPEC (OR 2.56, 95% CI [1.57, 4.31],
p
= 0.032) and the administration of preoperative systemic chemotherapy (OR = 1.59, 95% CI [1.26, 3.58],
p
= 0.041) were found to be independent factors related to the appearance of an incisional hernia.
Conclusions
The incidence of incisional hernia after cytoreduction and HIPEC is within the ranges described in the literature for other abdominal surgery procedures. The use of systemic chemotherapy and treatment with HIPEC, in particular, were identified as factors related to their occurrence
.</abstract><cop>Paris</cop><pub>Springer Paris</pub><pmid>31069579</pmid><doi>10.1007/s10029-019-01962-4</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1265-4906 |
| ispartof | Hernia : the journal of hernias and abdominal wall surgery, 2020-04, Vol.24 (2), p.257-263 |
| issn | 1265-4906 1248-9204 |
| language | eng |
| recordid | cdi_proquest_journals_2221563696 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Abdominal Surgery Adolescent Adult Aged Algorithms Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Chemotherapy Cytoreduction Surgical Procedures - adverse effects Female Forum on Complexities in Hernia Gastric cancer Hernia Hernias Herniorrhaphy Humans Hyperthermic Intraperitoneal Chemotherapy - adverse effects Incidence Incisional Hernia - epidemiology Incisional Hernia - etiology Incisional Hernia - surgery Medicine Medicine & Public Health Middle Aged Multivariate analysis Original Article Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Ovarian Neoplasms - surgery Patients Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - secondary Peritoneal Neoplasms - surgery Peritoneum Peritoneum - pathology Peritoneum - surgery Retrospective Studies Risk Factors Spain - epidemiology Surgery Young Adult |
| title | Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A04%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20and%20management%20of%20incisional%20hernia%20after%20cytoreduction%20and%20hyperthermic%20intraperitoneal%20chemotherapy%20(HIPEC)%20in%20patients%20with%20peritoneal%20surface%20malignancies&rft.jtitle=Hernia%20:%20the%20journal%20of%20hernias%20and%20abdominal%20wall%20surgery&rft.au=Cascales%20Campos,%20P.%20A.&rft.date=2020-04-01&rft.volume=24&rft.issue=2&rft.spage=257&rft.epage=263&rft.pages=257-263&rft.issn=1265-4906&rft.eissn=1248-9204&rft_id=info:doi/10.1007/s10029-019-01962-4&rft_dat=%3Cproquest_cross%3E2221563696%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2221563696&rft_id=info:pmid/31069579&rfr_iscdi=true |